FDG PET for Myocardial Viability

Medicare covers FDG PET to determine myocardial viability following an inconclusive SPECT (coverage from 2001-07-01 to 2002-09-30) and, beginning 2002-10-01, also as a primary diagnostic study prior to revascularization. Device requirements changed over time: only full-ring PET scanners were covered from 2001-07-01 to 2001-12-31, while full- and partial-ring scanners have been acceptable from 2002-01-01 onward. If FDG PET is inconclusive, a subsequent SPECT is not covered; referring physicians must document that coverage conditions are met in the beneficiary's medical record.

"FDG PET is covered for determination of myocardial viability following an inconclusive SPECT test for studies performed between 2001-07-01 and 2002-09-30."

Sign up to see full coverage criteria, indications, and limitations.